Article Information
History
- March 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xiansheng Huang1,
- Yiqi Zhang2,
- Wenqiang Zhu1,
- Piaopiao Huang1,
- Jingmei Xiao3,
- Yang Yang1,
- Li Shen1,
- Fei Luo1,4,
- Wen Dai1,5,
- Rong Li6,* and
- Renrong Wu3,*
- 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
- 2Department of Critical Care Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- 3National Clinical Research Center for Mental Disorders, and Department of Psychaitry, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China
- 4Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, The United States
- 5Department of Medicine, Columbia University Medical Center, New York, The United States
- 6Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
- ↵*Correspondence: Rong Li, Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China, #139 Middle Renmin Road, Changsha, Hunan 410011, China (E-mail: rongli{at}csu.edu.cn)., Renrong Wu, Department of Mental Health, The Second Xiangya Hospital, Central South University, #139 Middle Renmin Road, Changsha, Hunan 410011, China (E-mail: wurenrong{at}csu.edu.cn).
Posted March 01, 2021.
Olanzapine inhibits hepatic apolipoprotein A5 secretion inducing hypertriglyceridemia in schizophrenia patients and mice
